Wei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wei Wang has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Xiufang Kong
Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China
15 shared publications- Junnan Wu
Department of Nephrology, Zhejiang University Medical College Affiliated Sir Run Run Shaw Hospital, Hangzhou, China
2 shared publications Xue Li
National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing, China
2 shared publications- Bin Kang
Shanghai Children’s Medical Center–bioMérieux Laboratory, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication - Bing Han
Germplasm Bank of Wild Species, Yunnan Key Laboratory of Crop Wild Relatives Omics Kunming Institute of Botany, Chinese Academy of Sciences Kunming Yunnan China
1 shared publication - Chang Sheng Zhou
Department of Radiology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (5) , e70264
Associations of Cumulative Burden of Prehypertension, Prediabetes and Predyslipidemia With All‐Cause and Cardiovascular Disease Mortality: A Retrospective Cohort Study
We aimed to examine the individual and combined impact of prehypertension, prediabetes, and predyslipidemia on all‐cause and cardiovascular disease (CVD) mortality in community‐dwelling adults. A retrospective cohort study of 11 986 US adults from the 1999–2018 National Health and Nutrition Examination Survey was conducted. Participants were categorized into four mutually exclusive groups based on the cumulative number of these conditions. Multivariate Cox proportional hazards models were applied to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality outcomes. The prevalences of no, one, two, and all three preclinical conditions were 37.20%, 38.39%, 19.86%, and 4.55%, respectively. Over a median follow‐up of 10 years, 636 (3.83%) deaths occurred, including 170 (26.73%) from CVD. In a dose‐response manner, the adjusted HRs (95%CIs) for all‐cause mortality among those with one, two, and three conditions were 1.87 (1.38–2.52), 2.49 (1.80–3.44), and 2.62 (1.76–3.90), respectively, compared to those with none. The corresponding HRs (95%CIs) for CVD mortality were 3.09 (1.66–5.78), 3.89 (2.06–7.36), and 4.20 (2.04–8.69), respectively. Thus, an increasing cumulative number of preclinical conditions is associated with graded elevated risk of all‐cause and CVD mortality, underscoring the potential for early intervention during the preclinical phase to improve long‐term health outcomes.
- 30 April 2026
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 28 (5) , e70264
Open AccessAssociations of Cumulative Burden of Prehypertension, Prediabetes and Predyslipidemia With All‐Cause and Cardiovascular Disease Mortality: A Retrospective Cohort Study
We aimed to examine the individual and combined impact of prehypertension, prediabetes, and predyslipidemia on all‐cause and cardiovascular disease (CVD) mortality in community‐dwelling adults. A retrospective cohort study of 11 986 US adults from the 1999–2018 National Health and Nutrition Examination Survey was conducted. Participants were categorized into four mutually exclusive groups based on the cumulative number of these conditions. Multivariate Cox proportional hazards models were applied to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality outcomes. The prevalences of no, one, two, and all three preclinical conditions were 37.20%, 38.39%, 19.86%, and 4.55%, respectively. Over a median follow‐up of 10 years, 636 (3.83%) deaths occurred, including 170 (26.73%) from CVD. In a dose‐response manner, the adjusted HRs (95%CIs) for all‐cause mortality among those with one, two, and three conditions were 1.87 (1.38–2.52), 2.49 (1.80–3.44), and 2.62 (1.76–3.90), respectively, compared to those with none. The corresponding HRs (95%CIs) for CVD mortality were 3.09 (1.66–5.78), 3.89 (2.06–7.36), and 4.20 (2.04–8.69), respectively. Thus, an increasing cumulative number of preclinical conditions is associated with graded elevated risk of all‐cause and CVD mortality, underscoring the potential for early intervention during the preclinical phase to improve long‐term health outcomes.
- Open Access
- 16 June 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (8) , 2883-2884
Prevalence of Discordant Estimated GFR Among Adults in a Community-Based Population
- 16 June 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (8) , 2883-2884
Open AccessPrevalence of Discordant Estimated GFR Among Adults in a Community-Based Population
- 22 May 2025
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 49 (6) , 758-767
Association between handgrip strength asymmetry and all‐cause mortality in United States–based older adults: A cross‐sectional study
Background: Although handgrip strength is commonly measured in both hands for sarcopenia screening, the nonmaximum readings are frequently discarded. We aimed to evaluate whether handgrip strength asymmetry, in addition to weakness, could provide additional prognostic information in older adults.Methods: Participants aged ≥60 years from the 2011–2014 National Health and Nutrition Examination Survey with available handgrip strength measurements were included. Study outcomes are all‐cause and cardiovascular disease mortality. Participants were categorized into the weakness−/asymmetry− (reference), weakness−/asymmetry+, weakness+/asymmetry−, and weakness+/asymmetry+ groups based on the status of handgrip weakness and asymmetry.Results: Overall, 3116 older adults (mean age, 69.47 years) were included. Weighted percentages of participants in the reference, weakness−/asymmetry+, weakness+/asymmetry−, and weakness+/asymmetry+ groups were 54.28%, 39.88%, 2.86%, and 2.97%, respectively. During a median follow‐up of 79 months, 679 deaths (232 from cardiovascular causes) occurred. Compared with the reference group, hazard ratios (HRs) and 95% confidence intervals (CIs) for the weakness−/asymmetry+, weakness+/asymmetry−, and weakness+/asymmetry+ groups were 1.02 (95% CI 0.84–1.24), 1.57 (95% CI 1.09–2.26), and 2.34 (95% CI 1.47–3.71), respectively, for all‐cause mortality (P for trend < 0.01) and 1.19 (95% CI 0.78–1.81), 1.22 (95% CI 0.54–2.78), and 2.30 (95% CI 1.20–4.39), respectively, for cardiovascular disease mortality (P for trend = 0.03). Subgroup analysis indicated anemia and diabetes significantly modified the associations between handgrip strength and/or weakness status with all‐cause and cardiovascular disease mortality.Conclusion: Handgrip strength asymmetry, in addition to weakness, provided additional prognostic information for all‐cause and cardiovascular mortality in older adults in the United States.
- 22 May 2025
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 49 (6) , 758-767
Association between handgrip strength asymmetry and all‐cause mortality in United States–based older adults: A cross‐sectional study
Background: Although handgrip strength is commonly measured in both hands for sarcopenia screening, the nonmaximum readings are frequently discarded. We aimed to evaluate whether handgrip strength asymmetry, in addition to weakness, could provide additional prognostic information in older adults.Methods: Participants aged ≥60 years from the 2011–2014 National Health and Nutrition Examination Survey with available handgrip strength measurements were included. Study outcomes are all‐cause and cardiovascular disease mortality. Participants were categorized into the weakness−/asymmetry− (reference), weakness−/asymmetry+, weakness+/asymmetry−, and weakness+/asymmetry+ groups based on the status of handgrip weakness and asymmetry.Results: Overall, 3116 older adults (mean age, 69.47 years) were included. Weighted percentages of participants in the reference, weakness−/asymmetry+, weakness+/asymmetry−, and weakness+/asymmetry+ groups were 54.28%, 39.88%, 2.86%, and 2.97%, respectively. During a median follow‐up of 79 months, 679 deaths (232 from cardiovascular causes) occurred. Compared with the reference group, hazard ratios (HRs) and 95% confidence intervals (CIs) for the weakness−/asymmetry+, weakness+/asymmetry−, and weakness+/asymmetry+ groups were 1.02 (95% CI 0.84–1.24), 1.57 (95% CI 1.09–2.26), and 2.34 (95% CI 1.47–3.71), respectively, for all‐cause mortality (P for trend < 0.01) and 1.19 (95% CI 0.78–1.81), 1.22 (95% CI 0.54–2.78), and 2.30 (95% CI 1.20–4.39), respectively, for cardiovascular disease mortality (P for trend = 0.03). Subgroup analysis indicated anemia and diabetes significantly modified the associations between handgrip strength and/or weakness status with all‐cause and cardiovascular disease mortality.Conclusion: Handgrip strength asymmetry, in addition to weakness, provided additional prognostic information for all‐cause and cardiovascular mortality in older adults in the United States.
- Open Access
- 13 May 2025
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 22 (1) , 1-11
Sex differences in the associations between prior weight loss and all-cause or cardiovascular mortality in non-elderly individuals with hyperuricemia: a mortality follow-up study
Hyperuricemia, a common metabolic condition, is strongly associated with obesity and represents as an independent risk factor for elevated risk of mortality. This observational study aimed to examine the sex-specific associations of prior long-term weight loss (LTWL), defined as a sustained reduction in body weight maintained for at least 12 months, with all-cause and cardiovascular disease (CVD) mortality in non-elderly individuals with hyperuricemia. Non-elderly individuals with hyperuricemia and a historical maximum body mass index ≥ 25 kg/m2 from the 1999–2018 US National Health and Nutrition Examination Survey were included. Sex-specific associations between prior LTWL (< 5%, 5-9.9%, 10-14.9%, and ≥ 15%) with all-cause and CVD mortality were investigated by weighted multivariable Cox proportional hazard regression analysis and stratified analysis. Among 5,130 participants included, 505 all-cause (147 from CVD) deaths occurred during a median follow-up of 113 months. Compared with the LTWL < 5% reference group, the hazard ratios and 95% confidence intervals for the LTWL 5-9.9%, 10-14.9% and ≥ 15% groups were 1.11 (0.72–1.71), 1.34 (0.79–2.26) and 1.85 (1.14–2.92), respectively, for all-cause mortality (P for trend = 0.02) and 1.83 (0.76–4.43), 2.15 (0.76–6.10), and 3.76 (1.51–9.36), respectively, for CVD mortality (P for trend = 0.003). Significant associations between LTWL with all-cause and CVD mortality were observed exclusively in female, not male participants. Prior LTWL ≥ 5% was associated with increased all-cause and CVD mortality in US non-elderly female participants with hyperuricemia. Additional prospective and longitudinal randomized clinical trials are necessary to further examine the current findings.
- 13 May 2025
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 22 (1) , 1-11
Open AccessSex differences in the associations between prior weight loss and all-cause or cardiovascular mortality in non-elderly individuals with hyperuricemia: a mortality follow-up study
Hyperuricemia, a common metabolic condition, is strongly associated with obesity and represents as an independent risk factor for elevated risk of mortality. This observational study aimed to examine the sex-specific associations of prior long-term weight loss (LTWL), defined as a sustained reduction in body weight maintained for at least 12 months, with all-cause and cardiovascular disease (CVD) mortality in non-elderly individuals with hyperuricemia. Non-elderly individuals with hyperuricemia and a historical maximum body mass index ≥ 25 kg/m2 from the 1999–2018 US National Health and Nutrition Examination Survey were included. Sex-specific associations between prior LTWL (< 5%, 5-9.9%, 10-14.9%, and ≥ 15%) with all-cause and CVD mortality were investigated by weighted multivariable Cox proportional hazard regression analysis and stratified analysis. Among 5,130 participants included, 505 all-cause (147 from CVD) deaths occurred during a median follow-up of 113 months. Compared with the LTWL < 5% reference group, the hazard ratios and 95% confidence intervals for the LTWL 5-9.9%, 10-14.9% and ≥ 15% groups were 1.11 (0.72–1.71), 1.34 (0.79–2.26) and 1.85 (1.14–2.92), respectively, for all-cause mortality (P for trend = 0.02) and 1.83 (0.76–4.43), 2.15 (0.76–6.10), and 3.76 (1.51–9.36), respectively, for CVD mortality (P for trend = 0.003). Significant associations between LTWL with all-cause and CVD mortality were observed exclusively in female, not male participants. Prior LTWL ≥ 5% was associated with increased all-cause and CVD mortality in US non-elderly female participants with hyperuricemia. Additional prospective and longitudinal randomized clinical trials are necessary to further examine the current findings.
- Open Access
- 18 March 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2477302
Knowledge mapping and visualized analysis of research progress in onconephrology: a bibliometric analysis
Onconephrology is an expanding subspecialty focused on the management of cancer patients with renal injury. This study used a comprehensive bibliometric analysis to emphasize the need for cooperation between oncologists and nephrologists, exploring current trends and future research areas in onconephrology. Relevant literature on onconephrology published between 1 January 2000 and 27 April 2024 was retrieved from the Science Citation Index Expanded of the Web of Science Core Collection, followed by manual screening. Bibliometric analyses were performed using CiteSpace, VOSviewer, and Bibliometrix software. A total of 1,853 publications, including 1,647 articles and 206 reviews, by 11,606 authors from 2,757 institutions in 73 countries, were analyzed. Annual publications generally follow a steadily increasing trend, ranging from 25 to 161 documents. The United States (n = 464), The University of Texas MD Anderson Cancer Center (n = 39), Meletios A. Dimopoulos (n = 21), and Nephrology Dialysis Transplantation (n = 35) were the most productive country, institution, author, and journal, respectively. Immune checkpoint inhibitors, glomerular filtration rate, and cisplatin were clusters of highly cited references after 2015. Oxaliplatin, calcium, open-label, and thrombotic microangiopathy were trending topics after 2020. Outcome, acute kidney injury, immunotherapy, and chronic kidney disease were keyword bursts that persisted through 2024. Current research of onconephrology is focusing on chemotherapeutic nephrotoxicity, kidney function assessment, dosing of chemotherapeutic agents in chronic kidney disease, glomerular disease in cancer, immunotherapy, and electrolyte disturbances. Future directions in this field include clinical trials and thrombotic microangiopathy.
- 18 March 2025
- Published by Taylor & Francis in Renal Failure
- Vol. 47 (1) , 2477302
Open AccessKnowledge mapping and visualized analysis of research progress in onconephrology: a bibliometric analysis
Onconephrology is an expanding subspecialty focused on the management of cancer patients with renal injury. This study used a comprehensive bibliometric analysis to emphasize the need for cooperation between oncologists and nephrologists, exploring current trends and future research areas in onconephrology. Relevant literature on onconephrology published between 1 January 2000 and 27 April 2024 was retrieved from the Science Citation Index Expanded of the Web of Science Core Collection, followed by manual screening. Bibliometric analyses were performed using CiteSpace, VOSviewer, and Bibliometrix software. A total of 1,853 publications, including 1,647 articles and 206 reviews, by 11,606 authors from 2,757 institutions in 73 countries, were analyzed. Annual publications generally follow a steadily increasing trend, ranging from 25 to 161 documents. The United States (n = 464), The University of Texas MD Anderson Cancer Center (n = 39), Meletios A. Dimopoulos (n = 21), and Nephrology Dialysis Transplantation (n = 35) were the most productive country, institution, author, and journal, respectively. Immune checkpoint inhibitors, glomerular filtration rate, and cisplatin were clusters of highly cited references after 2015. Oxaliplatin, calcium, open-label, and thrombotic microangiopathy were trending topics after 2020. Outcome, acute kidney injury, immunotherapy, and chronic kidney disease were keyword bursts that persisted through 2024. Current research of onconephrology is focusing on chemotherapeutic nephrotoxicity, kidney function assessment, dosing of chemotherapeutic agents in chronic kidney disease, glomerular disease in cancer, immunotherapy, and electrolyte disturbances. Future directions in this field include clinical trials and thrombotic microangiopathy.
- 19 January 2025
- Published by Elsevier in Endocrine Practice
- Vol. 31 (4) , 486-493
Prediabetes Phenotypes and All-Cause or Cardiovascular Mortality: Evidence From a Population-Based Study
- 19 January 2025
- Published by Elsevier in Endocrine Practice
- Vol. 31 (4) , 486-493
Prediabetes Phenotypes and All-Cause or Cardiovascular Mortality: Evidence From a Population-Based Study
- 24 December 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 373, 44-50
L-shaped association between lipid accumulation products and depression: Insights from the National Health and nutrition examination survey 2005–2018
- 24 December 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 373, 44-50
L-shaped association between lipid accumulation products and depression: Insights from the National Health and nutrition examination survey 2005–2018
- Open Access
- 6 September 2024
- Published by Elsevier in Kidney International Reports
- Vol. 9 (11) , 3344-3345
Implications of the Choice of Different Calculation Concepts for eGFRcys-to-eGFRcre Ratio Among Community-Dwelling Older Adults
- 6 September 2024
- Published by Elsevier in Kidney International Reports
- Vol. 9 (11) , 3344-3345
Open AccessImplications of the Choice of Different Calculation Concepts for eGFRcys-to-eGFRcre Ratio Among Community-Dwelling Older Adults